# Dornase Alfa (Genetical Recombination) Inhalation Solution 2.5mg (プルモザイム吸入液２．５ｍｇ)

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 2290704G1024). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 2290704G1024
- **Product name (Japanese):** プルモザイム吸入液２．５ｍｇ
- **English title:** Dornase Alfa (Genetical Recombination) Inhalation Solution 2.5mg
- **Active ingredient:** ドルナーゼ アルファ（遺伝子組換え）
- **Active ingredient (INN):** Dornase Alfa (Genetical Recombination)
- **Strength / unit:** ２．５ｍｇ２．５ｍＬ１管
- **Route:** External / Topical (外用薬)
- **Therapeutic category:** 22 Respiratory agents (呼吸器官用薬) › 229 Other respiratory agents (その他の呼吸器官用薬)
- **Manufacturer:** Chugai Pharmaceutical (中外製薬)
- **NHI price (reference only):** JPY 6982.1 per ２．５ｍｇ２．５ｍＬ１管
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/2290704G1024
- **JSON:** https://www.nifujipharma.com/api/drugs/2290704G1024

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=Dornase%20Alfa%20(Genetical%20Recombination)%20Inhalation%20Solution%202.5mg%20(%E3%83%97%E3%83%AB%E3%83%A2%E3%82%B6%E3%82%A4%E3%83%A0%E5%90%B8%E5%85%A5%E6%B6%B2%EF%BC%92%EF%BC%8E%EF%BC%95%EF%BD%8D%EF%BD%87)%20%2F%20YJ%202290704G1024#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.